Abstract
Diagnostic galactomannan (GM) enzyme immunoassay (EIA) testing is formally validated only for serum, though in practice, plasma is occasionally tested. It is assumed, but not confirmed, that results will be comparable to those for serum. GM EIA when testing plasma was evaluated, providing sensitivity (85.7%) and specificity (85.4%) comparable to those for serum. Plasma index values were higher than those for serum; if plasma GM EIA were used to define probable cases, four additional cases would have been diagnosed. © 2013, American Society for Microbiology. All Rights Reserved.
Cite
CITATION STYLE
White, P. L., Jones, T., Whittle, K., Watkins, J., & Barnes, R. A. (2013). Comparison of galactomannan enzyme immunoassay performance levels when testing serum and plasma samples. Clinical and Vaccine Immunology, 20(4), 636–638. https://doi.org/10.1128/CVI.00730-12
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.